Selected research
Industry Research
Integrated Multi-Omics Services Industry Research Report 2026
Market perspective
The global Integrated Multi-Omics Services market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Integrated Multi-Omics Services market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Integrated Multi-Omics Services market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Integrated Multi-Omics Services market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Integrated Multi-Omics Services include Azenta Life Sciences, Eurofins, Source BioScience, Psomagen, Tempus, Evotec, Crown Bioscience, Sapient and Bruker Spatial Biology CRO Services, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Integrated Multi-Omics Services market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Integrated Multi-Omics Services.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Integrated Multi-Omics Services Market by Company
Azenta Life Sciences
Eurofins
Source BioScience
Psomagen
Tempus
Evotec
Crown Bioscience
Sapient
Bruker Spatial Biology CRO Services
Advanced Cell Diagnostics (ACD)
Panome Bio
RayBiotech
Metware Biotechnology
HaploX
Creative Proteomics
CD Genomics
Omics Empower
Cmbio
Dalton Bioanalytics
General Metabolics
Signios Bio
Source Genomics
Genechem
BGI Genomics
OE Biotech
BMKGENE
Majorbio
Wayen Biotechnologies
Integrated Multi-Omics Services Segment by Type
Dual-Omics Integration Services
Triple-Omics Integration Services
Quadruple & Above Multi-Omics Integration Services
Integrated Multi-Omics Services Segment by Application
Disease Research
Precision Medicine
Crop Breeding
Environmental Microbial Monitoring
Others
Integrated Multi-Omics Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Integrated Multi-Omics Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Integrated Multi-Omics Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Integrated Multi-Omics Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Integrated Multi-Omics Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 5. Global Integrated Multi-Omics Services Market Size by Type (2021-2026) & (US$ Million)
Table 6. Global Integrated Multi-Omics Services Revenue Market Share by Type (2021-2026)
Table 7. Global Integrated Multi-Omics Services Forecasted Market Size by Type (2027-2032) & (US$ Million)
Table 8. Global Integrated Multi-Omics Services Revenue Market Share by Type (2027-2032)
Table 9. Global Integrated Multi-Omics Services Market Size by Application (2021-2026) & (US$ Million)
Table 10. Global Integrated Multi-Omics Services Revenue Market Share by Application (2021-2026)
Table 11. Global Integrated Multi-Omics Services Forecasted Market Size by Application (2027-2032) & (US$ Million)
Table 12. Global Integrated Multi-Omics Services Revenue Market Share by Application (2027-2032)
Table 13. Global Integrated Multi-Omics Services Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Table 14. Global Integrated Multi-Omics Services Market Size by Region (2021-2026) & (US$ Million)
Table 15. Global Integrated Multi-Omics Services Market Share by Region (2021-2026)
Table 16. Global Integrated Multi-Omics Services Forecasted Market Size by Region (2027-2032) & (US$ Million)
Table 17. Global Integrated Multi-Omics Services Market Share by Region (2027-2032)
Table 18. Integrated Multi-Omics Services Industry Trends
Table 19. Integrated Multi-Omics Services Industry Drivers
Table 20. Integrated Multi-Omics Services Industry Opportunities and Challenges
Table 21. Integrated Multi-Omics Services Market Restraints
Table 22. Global Top Integrated Multi-Omics Services Players by Revenue (US$ Million) & (2021-2026)
Table 23. Global Integrated Multi-Omics Services Revenue Market Share by Players (2021-2026)
Table 24. Global Integrated Multi-Omics Services Industry Players Ranking, 2024 VS 2025 VS 2026
Table 25. Global Key Players of Integrated Multi-Omics Services, Headquarters and Area Served
Table 26. Global Integrated Multi-Omics Services Players, Product Type & Application
Table 27. Global Players Market Concentration Ratio (CR5 and HHI)
Table 28. Global Integrated Multi-Omics Services by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 29. Players Mergers & Acquisitions, Expansion Plans
Table 30. North America Integrated Multi-Omics Services Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 31. North America Integrated Multi-Omics Services Market Size by Country (2021-2026) & (US$ Million)
Table 32. North America Integrated Multi-Omics Services Market Size by Country (2027-2032) & (US$ Million)
Table 33. Europe Integrated Multi-Omics Services Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 34. Europe Integrated Multi-Omics Services Market Size by Country (2021-2026) & (US$ Million)
Table 35. Europe Integrated Multi-Omics Services Market Size by Country (2027-2032) & (US$ Million)
Table 36. Asia Pacific Integrated Multi-Omics Services Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 37. Asia Pacific Integrated Multi-Omics Services Market Size by Region (2021-2026) & (US$ Million)
Table 38. Asia Pacific Integrated Multi-Omics Services Market Size by Country (2027-2032) & (US$ Million)
Table 39. South America Integrated Multi-Omics Services Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 40. South America Integrated Multi-Omics Services Market Size by Country (2021-2026) & (US$ Million)
Table 41. South America Integrated Multi-Omics Services Market Size by Country (2027-2032) & (US$ Million)
Table 42. Middle East & Africa Integrated Multi-Omics Services Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 43. Middle East & Africa Integrated Multi-Omics Services Market Size by Country (2021-2026) & (US$ Million)
Table 44. Middle East & Africa Integrated Multi-Omics Services Market Size by Country (2027-2032) & (US$ Million)
Table 45. Azenta Life Sciences Company Information
Table 46. Azenta Life Sciences Business Overview
Table 47. Azenta Life Sciences Revenue in Integrated Multi-Omics Services Business (2021-2026) & (US$ Million)
Table 48. Azenta Life Sciences Integrated Multi-Omics Services Product Portfolio
Table 49. Azenta Life Sciences Recent Developments
Table 50. Eurofins Company Information
Table 51. Eurofins Business Overview
Table 52. Eurofins Revenue in Integrated Multi-Omics Services Business (2021-2026) & (US$ Million)
Table 53. Eurofins Integrated Multi-Omics Services Product Portfolio
Table 54. Eurofins Recent Developments
Table 55. Source BioScience Company Information
Table 56. Source BioScience Business Overview
Table 57. Source BioScience Revenue in Integrated Multi-Omics Services Business (2021-2026) & (US$ Million)
Table 58. Source BioScience Integrated Multi-Omics Services Product Portfolio
Table 59. Source BioScience Recent Developments
Table 60. Psomagen Company Information
Table 61. Psomagen Business Overview
Table 62. Psomagen Revenue in Integrated Multi-Omics Services Business (2021-2026) & (US$ Million)
Table 63. Psomagen Integrated Multi-Omics Services Product Portfolio
Table 64. Psomagen Recent Developments
Table 65. Tempus Company Information
Table 66. Tempus Business Overview
Table 67. Tempus Revenue in Integrated Multi-Omics Services Business (2021-2026) & (US$ Million)
Table 68. Tempus Integrated Multi-Omics Services Product Portfolio
Table 69. Tempus Recent Developments
Table 70. Evotec Company Information
Table 71. Evotec Business Overview
Table 72. Evotec Revenue in Integrated Multi-Omics Services Business (2021-2026) & (US$ Million)
Table 73. Evotec Integrated Multi-Omics Services Product Portfolio
Table 74. Evotec Recent Developments
Table 75. Crown Bioscience Company Information
Table 76. Crown Bioscience Business Overview
Table 77. Crown Bioscience Revenue in Integrated Multi-Omics Services Business (2021-2026) & (US$ Million)
Table 78. Crown Bioscience Integrated Multi-Omics Services Product Portfolio
Table 79. Crown Bioscience Recent Developments
Table 80. Sapient Company Information
Table 81. Sapient Business Overview
Table 82. Sapient Revenue in Integrated Multi-Omics Services Business (2021-2026) & (US$ Million)
Table 83. Sapient Integrated Multi-Omics Services Product Portfolio
Table 84. Sapient Recent Developments
Table 85. Bruker Spatial Biology CRO Services Company Information
Table 86. Bruker Spatial Biology CRO Services Business Overview
Table 87. Bruker Spatial Biology CRO Services Revenue in Integrated Multi-Omics Services Business (2021-2026) & (US$ Million)
Table 88. Bruker Spatial Biology CRO Services Integrated Multi-Omics Services Product Portfolio
Table 89. Bruker Spatial Biology CRO Services Recent Developments
Table 90. Advanced Cell Diagnostics (ACD) Company Information
Table 91. Advanced Cell Diagnostics (ACD) Business Overview
Table 92. Advanced Cell Diagnostics (ACD) Revenue in Integrated Multi-Omics Services Business (2021-2026) & (US$ Million)
Table 93. Advanced Cell Diagnostics (ACD) Integrated Multi-Omics Services Product Portfolio
Table 94. Advanced Cell Diagnostics (ACD) Recent Developments
Table 95. Panome Bio Company Information
Table 96. Panome Bio Business Overview
Table 97. Panome Bio Revenue in Integrated Multi-Omics Services Business (2021-2026) & (US$ Million)
Table 98. Panome Bio Integrated Multi-Omics Services Product Portfolio
Table 99. Panome Bio Recent Developments
Table 100. RayBiotech Company Information
Table 101. RayBiotech Business Overview
Table 102. RayBiotech Revenue in Integrated Multi-Omics Services Business (2021-2026) & (US$ Million)
Table 103. RayBiotech Integrated Multi-Omics Services Product Portfolio
Table 104. RayBiotech Recent Developments
Table 105. Metware Biotechnology Company Information
Table 106. Metware Biotechnology Business Overview
Table 107. Metware Biotechnology Revenue in Integrated Multi-Omics Services Business (2021-2026) & (US$ Million)
Table 108. Metware Biotechnology Integrated Multi-Omics Services Product Portfolio
Table 109. Metware Biotechnology Recent Developments
Table 110. HaploX Company Information
Table 111. HaploX Business Overview
Table 112. HaploX Revenue in Integrated Multi-Omics Services Business (2021-2026) & (US$ Million)
Table 113. HaploX Integrated Multi-Omics Services Product Portfolio
Table 114. HaploX Recent Developments
Table 115. Creative Proteomics Company Information
Table 116. Creative Proteomics Business Overview
Table 117. Creative Proteomics Revenue in Integrated Multi-Omics Services Business (2021-2026) & (US$ Million)
Table 118. Creative Proteomics Integrated Multi-Omics Services Product Portfolio
Table 119. Creative Proteomics Recent Developments
Table 120. CD Genomics Company Information
Table 121. CD Genomics Business Overview
Table 122. CD Genomics Revenue in Integrated Multi-Omics Services Business (2021-2026) & (US$ Million)
Table 123. CD Genomics Integrated Multi-Omics Services Product Portfolio
Table 124. CD Genomics Recent Developments
Table 125. Omics Empower Company Information
Table 126. Omics Empower Business Overview
Table 127. Omics Empower Revenue in Integrated Multi-Omics Services Business (2021-2026) & (US$ Million)
Table 128. Omics Empower Integrated Multi-Omics Services Product Portfolio
Table 129. Omics Empower Recent Developments
Table 130. Cmbio Company Information
Table 131. Cmbio Business Overview
Table 132. Cmbio Revenue in Integrated Multi-Omics Services Business (2021-2026) & (US$ Million)
Table 133. Cmbio Integrated Multi-Omics Services Product Portfolio
Table 134. Cmbio Recent Developments
Table 135. Dalton Bioanalytics Company Information
Table 136. Dalton Bioanalytics Business Overview
Table 137. Dalton Bioanalytics Revenue in Integrated Multi-Omics Services Business (2021-2026) & (US$ Million)
Table 138. Dalton Bioanalytics Integrated Multi-Omics Services Product Portfolio
Table 139. Dalton Bioanalytics Recent Developments
Table 140. General Metabolics Company Information
Table 141. General Metabolics Business Overview
Table 142. General Metabolics Revenue in Integrated Multi-Omics Services Business (2021-2026) & (US$ Million)
Table 143. General Metabolics Integrated Multi-Omics Services Product Portfolio
Table 144. General Metabolics Recent Developments
Table 145. Signios Bio Company Information
Table 146. Signios Bio Business Overview
Table 147. Signios Bio Revenue in Integrated Multi-Omics Services Business (2021-2026) & (US$ Million)
Table 148. Signios Bio Integrated Multi-Omics Services Product Portfolio
Table 149. Signios Bio Recent Developments
Table 150. Source Genomics Company Information
Table 151. Source Genomics Business Overview
Table 152. Source Genomics Revenue in Integrated Multi-Omics Services Business (2021-2026) & (US$ Million)
Table 153. Source Genomics Integrated Multi-Omics Services Product Portfolio
Table 154. Source Genomics Recent Developments
Table 155. Genechem Company Information
Table 156. Genechem Business Overview
Table 157. Genechem Revenue in Integrated Multi-Omics Services Business (2021-2026) & (US$ Million)
Table 158. Genechem Integrated Multi-Omics Services Product Portfolio
Table 159. Genechem Recent Developments
Table 160. BGI Genomics Company Information
Table 161. BGI Genomics Business Overview
Table 162. BGI Genomics Revenue in Integrated Multi-Omics Services Business (2021-2026) & (US$ Million)
Table 163. BGI Genomics Integrated Multi-Omics Services Product Portfolio
Table 164. BGI Genomics Recent Developments
Table 165. OE Biotech Company Information
Table 166. OE Biotech Business Overview
Table 167. OE Biotech Revenue in Integrated Multi-Omics Services Business (2021-2026) & (US$ Million)
Table 168. OE Biotech Integrated Multi-Omics Services Product Portfolio
Table 169. OE Biotech Recent Developments
Table 170. BMKGENE Company Information
Table 171. BMKGENE Business Overview
Table 172. BMKGENE Revenue in Integrated Multi-Omics Services Business (2021-2026) & (US$ Million)
Table 173. BMKGENE Integrated Multi-Omics Services Product Portfolio
Table 174. BMKGENE Recent Developments
Table 175. Majorbio Company Information
Table 176. Majorbio Business Overview
Table 177. Majorbio Revenue in Integrated Multi-Omics Services Business (2021-2026) & (US$ Million)
Table 178. Majorbio Integrated Multi-Omics Services Product Portfolio
Table 179. Majorbio Recent Developments
Table 180. Wayen Biotechnologies Company Information
Table 181. Wayen Biotechnologies Business Overview
Table 182. Wayen Biotechnologies Revenue in Integrated Multi-Omics Services Business (2021-2026) & (US$ Million)
Table 183. Wayen Biotechnologies Integrated Multi-Omics Services Product Portfolio
Table 184. Wayen Biotechnologies Recent Developments
Table 185. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Integrated Multi-Omics Services Product Image
Figure 5. Global Integrated Multi-Omics Services Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 6. Global Integrated Multi-Omics Services Market Share by Type: 2025 VS 2032
Figure 7. Dual-Omics Integration Services Product
Figure 8. Triple-Omics Integration Services Product
Figure 9. Quadruple & Above Multi-Omics Integration Services Product
Figure 10. Global Integrated Multi-Omics Services Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 11. Global Integrated Multi-Omics Services Market Share by Application: 2025 VS 2032
Figure 12. Disease Research Product
Figure 13. Precision Medicine Product
Figure 14. Crop Breeding Product
Figure 15. Environmental Microbial Monitoring Product
Figure 16. Others Product
Figure 17. Global Integrated Multi-Omics Services Market Size (US$ Million), Year-over-Year: 2021-2032
Figure 18. Global Integrated Multi-Omics Services Market Size, (US$ Million), 2021 VS 2025 VS 2032
Figure 19. Global Integrated Multi-Omics Services Market Share by Region: 2025 VS 2032
Figure 20. Global Integrated Multi-Omics Services Market Share by Players in 2025
Figure 21. Global Integrated Multi-Omics Services Manufacturers Established Date
Figure 22. Global Top 5 and 10 Integrated Multi-Omics Services Players Market Share by Revenue in 2025
Figure 23. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 24. North America Integrated Multi-Omics Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 25. North America Integrated Multi-Omics Services Market Share by Country (2021-2032)
Figure 26. United States Integrated Multi-Omics Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 27. Canada Integrated Multi-Omics Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 28. Mexico Integrated Multi-Omics Services Market Share by Country (2021-2032)
Figure 29. Europe Integrated Multi-Omics Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 30. Europe Integrated Multi-Omics Services Market Share by Country (2021-2032)
Figure 31. Germany Integrated Multi-Omics Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 32. France Integrated Multi-Omics Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 33. U.K. Integrated Multi-Omics Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 34. Italy Integrated Multi-Omics Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 35. Spain Integrated Multi-Omics Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 36. Russia Integrated Multi-Omics Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 37. Netherlands Integrated Multi-Omics Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 38. Nordic Countries Integrated Multi-Omics Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 39. Asia-Pacific Integrated Multi-Omics Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 40. Asia-Pacific Integrated Multi-Omics Services Market Share by Country (2021-2032)
Figure 41. China Integrated Multi-Omics Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 42. Japan Integrated Multi-Omics Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 43. South Korea Integrated Multi-Omics Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 44. India Integrated Multi-Omics Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 45. India Integrated Multi-Omics Services Market Share by Country (2021-2032)
Figure 46. Australia Integrated Multi-Omics Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 47. China Taiwan Integrated Multi-Omics Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 48. Southeast Asia Integrated Multi-Omics Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 49. South America Integrated Multi-Omics Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 50. South America Integrated Multi-Omics Services Market Share by Country (2021-2032)
Figure 51. Brazil Integrated Multi-Omics Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 52. Argentina Integrated Multi-Omics Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 53. Chile Integrated Multi-Omics Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 54. Colombia Integrated Multi-Omics Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 55. Peru Integrated Multi-Omics Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 56. Azenta Life Sciences Revenue Growth Rate in Integrated Multi-Omics Services Business (2021-2026)
Figure 57. Eurofins Revenue Growth Rate in Integrated Multi-Omics Services Business (2021-2026)
Figure 58. Source BioScience Revenue Growth Rate in Integrated Multi-Omics Services Business (2021-2026)
Figure 59. Psomagen Revenue Growth Rate in Integrated Multi-Omics Services Business (2021-2026)
Figure 60. Tempus Revenue Growth Rate in Integrated Multi-Omics Services Business (2021-2026)
Figure 61. Evotec Revenue Growth Rate in Integrated Multi-Omics Services Business (2021-2026)
Figure 62. Crown Bioscience Revenue Growth Rate in Integrated Multi-Omics Services Business (2021-2026)
Figure 63. Sapient Revenue Growth Rate in Integrated Multi-Omics Services Business (2021-2026)
Figure 64. Bruker Spatial Biology CRO Services Revenue Growth Rate in Integrated Multi-Omics Services Business (2021-2026)
Figure 65. Advanced Cell Diagnostics (ACD) Revenue Growth Rate in Integrated Multi-Omics Services Business (2021-2026)
Figure 66. Panome Bio Revenue Growth Rate in Integrated Multi-Omics Services Business (2021-2026)
Figure 67. RayBiotech Revenue Growth Rate in Integrated Multi-Omics Services Business (2021-2026)
Figure 68. Metware Biotechnology Revenue Growth Rate in Integrated Multi-Omics Services Business (2021-2026)
Figure 69. HaploX Revenue Growth Rate in Integrated Multi-Omics Services Business (2021-2026)
Figure 70. Creative Proteomics Revenue Growth Rate in Integrated Multi-Omics Services Business (2021-2026)
Figure 71. CD Genomics Revenue Growth Rate in Integrated Multi-Omics Services Business (2021-2026)
Figure 72. Omics Empower Revenue Growth Rate in Integrated Multi-Omics Services Business (2021-2026)
Figure 73. Cmbio Revenue Growth Rate in Integrated Multi-Omics Services Business (2021-2026)
Figure 74. Dalton Bioanalytics Revenue Growth Rate in Integrated Multi-Omics Services Business (2021-2026)
Figure 75. General Metabolics Revenue Growth Rate in Integrated Multi-Omics Services Business (2021-2026)
Figure 76. Signios Bio Revenue Growth Rate in Integrated Multi-Omics Services Business (2021-2026)
Figure 77. Source Genomics Revenue Growth Rate in Integrated Multi-Omics Services Business (2021-2026)
Figure 78. Genechem Revenue Growth Rate in Integrated Multi-Omics Services Business (2021-2026)
Figure 79. BGI Genomics Revenue Growth Rate in Integrated Multi-Omics Services Business (2021-2026)
Figure 80. OE Biotech Revenue Growth Rate in Integrated Multi-Omics Services Business (2021-2026)
Figure 81. BMKGENE Revenue Growth Rate in Integrated Multi-Omics Services Business (2021-2026)
Figure 82. Majorbio Revenue Growth Rate in Integrated Multi-Omics Services Business (2021-2026)
Figure 83. Wayen Biotechnologies Revenue Growth Rate in Integrated Multi-Omics Services Business (2021-2026)
Scope & coverage.
Types
- Dual-Omics Integration Services
- Triple-Omics Integration Services
- Quadruple & Above Multi-Omics Integration Services
Applications
- Disease Research
- Precision Medicine
- Crop Breeding
- Environmental Microbial Monitoring
- Others
Companies covered
- Azenta Life Sciences
- Eurofins
- Source BioScience
- Psomagen
- Tempus
- Evotec
- Crown Bioscience
- Sapient
- Bruker Spatial Biology CRO Services
- Advanced Cell Diagnostics (ACD)
- Panome Bio
- RayBiotech
- Metware Biotechnology
- HaploX
- Creative Proteomics
- CD Genomics
- Omics Empower
- Cmbio
- Dalton Bioanalytics
- General Metabolics
- Signios Bio
- Source Genomics
- Genechem
- BGI Genomics
- OE Biotech
- BMKGENE
- Majorbio
- Wayen Biotechnologies
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Integrated Multi-Omics Services by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Dual-Omics Integration Services
- 2.2.3 Triple-Omics Integration Services
- 2.2.4 Quadruple & Above Multi-Omics Integration Services
- 2.3 Integrated Multi-Omics Services by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Disease Research
- 2.3.3 Precision Medicine
- 2.3.4 Crop Breeding
- 2.3.5 Environmental Microbial Monitoring
- 2.3.6 Others
- 2.4 Assumptions and Limitations
3 Integrated Multi-Omics Services Breakdown Data by Type
- 3.1 Global Integrated Multi-Omics Services Historic Market Size by Type (2021-2026)
- 3.2 Global Integrated Multi-Omics Services Forecasted Market Size by Type (2027-2032)
4 Integrated Multi-Omics Services Breakdown Data by Application
- 4.1 Global Integrated Multi-Omics Services Historic Market Size by Application (2021-2026)
- 4.2 Global Integrated Multi-Omics Services Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Integrated Multi-Omics Services Market Perspective (2021-2032)
- 5.2 Global Integrated Multi-Omics Services Growth Trends by Region
- 5.2.1 Global Integrated Multi-Omics Services Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Integrated Multi-Omics Services Historic Market Size by Region (2021-2026)
- 5.2.3 Integrated Multi-Omics Services Forecasted Market Size by Region (2027-2032)
- 5.3 Integrated Multi-Omics Services Market Dynamics
- 5.3.1 Integrated Multi-Omics Services Industry Trends
- 5.3.2 Integrated Multi-Omics Services Market Drivers
- 5.3.3 Integrated Multi-Omics Services Market Challenges
- 5.3.4 Integrated Multi-Omics Services Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Integrated Multi-Omics Services Players by Revenue
- 6.1.1 Global Top Integrated Multi-Omics Services Players by Revenue (2021-2026)
- 6.1.2 Global Integrated Multi-Omics Services Revenue Market Share by Players (2021-2026)
- 6.2 Global Integrated Multi-Omics Services Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Integrated Multi-Omics Services Head Office and Area Served
- 6.4 Global Integrated Multi-Omics Services Players, Product Type & Application
- 6.5 Global Integrated Multi-Omics Services Manufacturers Established Date
- 6.6 Global Integrated Multi-Omics Services Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Integrated Multi-Omics Services Market Size (2021-2032)
- 7.2 North America Integrated Multi-Omics Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Integrated Multi-Omics Services Market Size by Country (2021-2026)
- 7.4 North America Integrated Multi-Omics Services Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Integrated Multi-Omics Services Market Size (2021-2032)
- 8.2 Europe Integrated Multi-Omics Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Integrated Multi-Omics Services Market Size by Country (2021-2026)
- 8.4 Europe Integrated Multi-Omics Services Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Integrated Multi-Omics Services Market Size (2021-2032)
- 9.2 Asia-Pacific Integrated Multi-Omics Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Integrated Multi-Omics Services Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Integrated Multi-Omics Services Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Integrated Multi-Omics Services Market Size (2021-2032)
- 10.2 South America Integrated Multi-Omics Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Integrated Multi-Omics Services Market Size by Country (2021-2026)
- 10.4 South America Integrated Multi-Omics Services Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Integrated Multi-Omics Services Market Size (2021-2032)
- 11.2 Middle East & Africa Integrated Multi-Omics Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Integrated Multi-Omics Services Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Integrated Multi-Omics Services Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Azenta Life Sciences
- 12.1.1 Azenta Life Sciences Company Information
- 12.1.2 Azenta Life Sciences Business Overview
- 12.1.3 Azenta Life Sciences Revenue in Integrated Multi-Omics Services Business (2021-2026)
- 12.1.4 Azenta Life Sciences Integrated Multi-Omics Services Product Portfolio
- 12.1.5 Azenta Life Sciences Recent Developments
- 12.2 Eurofins
- 12.2.1 Eurofins Company Information
- 12.2.2 Eurofins Business Overview
- 12.2.3 Eurofins Revenue in Integrated Multi-Omics Services Business (2021-2026)
- 12.2.4 Eurofins Integrated Multi-Omics Services Product Portfolio
- 12.2.5 Eurofins Recent Developments
- 12.3 Source BioScience
- 12.3.1 Source BioScience Company Information
- 12.3.2 Source BioScience Business Overview
- 12.3.3 Source BioScience Revenue in Integrated Multi-Omics Services Business (2021-2026)
- 12.3.4 Source BioScience Integrated Multi-Omics Services Product Portfolio
- 12.3.5 Source BioScience Recent Developments
- 12.4 Psomagen
- 12.4.1 Psomagen Company Information
- 12.4.2 Psomagen Business Overview
- 12.4.3 Psomagen Revenue in Integrated Multi-Omics Services Business (2021-2026)
- 12.4.4 Psomagen Integrated Multi-Omics Services Product Portfolio
- 12.4.5 Psomagen Recent Developments
- 12.5 Tempus
- 12.5.1 Tempus Company Information
- 12.5.2 Tempus Business Overview
- 12.5.3 Tempus Revenue in Integrated Multi-Omics Services Business (2021-2026)
- 12.5.4 Tempus Integrated Multi-Omics Services Product Portfolio
- 12.5.5 Tempus Recent Developments
- 12.6 Evotec
- 12.6.1 Evotec Company Information
- 12.6.2 Evotec Business Overview
- 12.6.3 Evotec Revenue in Integrated Multi-Omics Services Business (2021-2026)
- 12.6.4 Evotec Integrated Multi-Omics Services Product Portfolio
- 12.6.5 Evotec Recent Developments
- 12.7 Crown Bioscience
- 12.7.1 Crown Bioscience Company Information
- 12.7.2 Crown Bioscience Business Overview
- 12.7.3 Crown Bioscience Revenue in Integrated Multi-Omics Services Business (2021-2026)
- 12.7.4 Crown Bioscience Integrated Multi-Omics Services Product Portfolio
- 12.7.5 Crown Bioscience Recent Developments
- 12.8 Sapient
- 12.8.1 Sapient Company Information
- 12.8.2 Sapient Business Overview
- 12.8.3 Sapient Revenue in Integrated Multi-Omics Services Business (2021-2026)
- 12.8.4 Sapient Integrated Multi-Omics Services Product Portfolio
- 12.8.5 Sapient Recent Developments
- 12.9 Bruker Spatial Biology CRO Services
- 12.9.1 Bruker Spatial Biology CRO Services Company Information
- 12.9.2 Bruker Spatial Biology CRO Services Business Overview
- 12.9.3 Bruker Spatial Biology CRO Services Revenue in Integrated Multi-Omics Services Business (2021-2026)
- 12.9.4 Bruker Spatial Biology CRO Services Integrated Multi-Omics Services Product Portfolio
- 12.9.5 Bruker Spatial Biology CRO Services Recent Developments
- 12.10 Advanced Cell Diagnostics (ACD)
- 12.10.1 Advanced Cell Diagnostics (ACD) Company Information
- 12.10.2 Advanced Cell Diagnostics (ACD) Business Overview
- 12.10.3 Advanced Cell Diagnostics (ACD) Revenue in Integrated Multi-Omics Services Business (2021-2026)
- 12.10.4 Advanced Cell Diagnostics (ACD) Integrated Multi-Omics Services Product Portfolio
- 12.10.5 Advanced Cell Diagnostics (ACD) Recent Developments
- 12.11 Panome Bio
- 12.11.1 Panome Bio Company Information
- 12.11.2 Panome Bio Business Overview
- 12.11.3 Panome Bio Revenue in Integrated Multi-Omics Services Business (2021-2026)
- 12.11.4 Panome Bio Integrated Multi-Omics Services Product Portfolio
- 12.11.5 Panome Bio Recent Developments
- 12.12 RayBiotech
- 12.12.1 RayBiotech Company Information
- 12.12.2 RayBiotech Business Overview
- 12.12.3 RayBiotech Revenue in Integrated Multi-Omics Services Business (2021-2026)
- 12.12.4 RayBiotech Integrated Multi-Omics Services Product Portfolio
- 12.12.5 RayBiotech Recent Developments
- 12.13 Metware Biotechnology
- 12.13.1 Metware Biotechnology Company Information
- 12.13.2 Metware Biotechnology Business Overview
- 12.13.3 Metware Biotechnology Revenue in Integrated Multi-Omics Services Business (2021-2026)
- 12.13.4 Metware Biotechnology Integrated Multi-Omics Services Product Portfolio
- 12.13.5 Metware Biotechnology Recent Developments
- 12.14 HaploX
- 12.14.1 HaploX Company Information
- 12.14.2 HaploX Business Overview
- 12.14.3 HaploX Revenue in Integrated Multi-Omics Services Business (2021-2026)
- 12.14.4 HaploX Integrated Multi-Omics Services Product Portfolio
- 12.14.5 HaploX Recent Developments
- 12.15 Creative Proteomics
- 12.15.1 Creative Proteomics Company Information
- 12.15.2 Creative Proteomics Business Overview
- 12.15.3 Creative Proteomics Revenue in Integrated Multi-Omics Services Business (2021-2026)
- 12.15.4 Creative Proteomics Integrated Multi-Omics Services Product Portfolio
- 12.15.5 Creative Proteomics Recent Developments
- 12.16 CD Genomics
- 12.16.1 CD Genomics Company Information
- 12.16.2 CD Genomics Business Overview
- 12.16.3 CD Genomics Revenue in Integrated Multi-Omics Services Business (2021-2026)
- 12.16.4 CD Genomics Integrated Multi-Omics Services Product Portfolio
- 12.16.5 CD Genomics Recent Developments
- 12.17 Omics Empower
- 12.17.1 Omics Empower Company Information
- 12.17.2 Omics Empower Business Overview
- 12.17.3 Omics Empower Revenue in Integrated Multi-Omics Services Business (2021-2026)
- 12.17.4 Omics Empower Integrated Multi-Omics Services Product Portfolio
- 12.17.5 Omics Empower Recent Developments
- 12.18 Cmbio
- 12.18.1 Cmbio Company Information
- 12.18.2 Cmbio Business Overview
- 12.18.3 Cmbio Revenue in Integrated Multi-Omics Services Business (2021-2026)
- 12.18.4 Cmbio Integrated Multi-Omics Services Product Portfolio
- 12.18.5 Cmbio Recent Developments
- 12.19 Dalton Bioanalytics
- 12.19.1 Dalton Bioanalytics Company Information
- 12.19.2 Dalton Bioanalytics Business Overview
- 12.19.3 Dalton Bioanalytics Revenue in Integrated Multi-Omics Services Business (2021-2026)
- 12.19.4 Dalton Bioanalytics Integrated Multi-Omics Services Product Portfolio
- 12.19.5 Dalton Bioanalytics Recent Developments
- 12.20 General Metabolics
- 12.20.1 General Metabolics Company Information
- 12.20.2 General Metabolics Business Overview
- 12.20.3 General Metabolics Revenue in Integrated Multi-Omics Services Business (2021-2026)
- 12.20.4 General Metabolics Integrated Multi-Omics Services Product Portfolio
- 12.20.5 General Metabolics Recent Developments
- 12.21 Signios Bio
- 12.21.1 Signios Bio Company Information
- 12.21.2 Signios Bio Business Overview
- 12.21.3 Signios Bio Revenue in Integrated Multi-Omics Services Business (2021-2026)
- 12.21.4 Signios Bio Integrated Multi-Omics Services Product Portfolio
- 12.21.5 Signios Bio Recent Developments
- 12.22 Source Genomics
- 12.22.1 Source Genomics Company Information
- 12.22.2 Source Genomics Business Overview
- 12.22.3 Source Genomics Revenue in Integrated Multi-Omics Services Business (2021-2026)
- 12.22.4 Source Genomics Integrated Multi-Omics Services Product Portfolio
- 12.22.5 Source Genomics Recent Developments
- 12.23 Genechem
- 12.23.1 Genechem Company Information
- 12.23.2 Genechem Business Overview
- 12.23.3 Genechem Revenue in Integrated Multi-Omics Services Business (2021-2026)
- 12.23.4 Genechem Integrated Multi-Omics Services Product Portfolio
- 12.23.5 Genechem Recent Developments
- 12.24 BGI Genomics
- 12.24.1 BGI Genomics Company Information
- 12.24.2 BGI Genomics Business Overview
- 12.24.3 BGI Genomics Revenue in Integrated Multi-Omics Services Business (2021-2026)
- 12.24.4 BGI Genomics Integrated Multi-Omics Services Product Portfolio
- 12.24.5 BGI Genomics Recent Developments
- 12.25 OE Biotech
- 12.25.1 OE Biotech Company Information
- 12.25.2 OE Biotech Business Overview
- 12.25.3 OE Biotech Revenue in Integrated Multi-Omics Services Business (2021-2026)
- 12.25.4 OE Biotech Integrated Multi-Omics Services Product Portfolio
- 12.25.5 OE Biotech Recent Developments
- 12.26 BMKGENE
- 12.26.1 BMKGENE Company Information
- 12.26.2 BMKGENE Business Overview
- 12.26.3 BMKGENE Revenue in Integrated Multi-Omics Services Business (2021-2026)
- 12.26.4 BMKGENE Integrated Multi-Omics Services Product Portfolio
- 12.26.5 BMKGENE Recent Developments
- 12.27 Majorbio
- 12.27.1 Majorbio Company Information
- 12.27.2 Majorbio Business Overview
- 12.27.3 Majorbio Revenue in Integrated Multi-Omics Services Business (2021-2026)
- 12.27.4 Majorbio Integrated Multi-Omics Services Product Portfolio
- 12.27.5 Majorbio Recent Developments
- 12.28 Wayen Biotechnologies
- 12.28.1 Wayen Biotechnologies Company Information
- 12.28.2 Wayen Biotechnologies Business Overview
- 12.28.3 Wayen Biotechnologies Revenue in Integrated Multi-Omics Services Business (2021-2026)
- 12.28.4 Wayen Biotechnologies Integrated Multi-Omics Services Product Portfolio
- 12.28.5 Wayen Biotechnologies Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$2,950USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst